• The 5th annual E-Cigarette Summit will take place on Friday 17th November at The Royal Society, London
  • Registration for the E-Cigarette Summit 2017 is now open

Professor David Spiegelhalter FRS

Winton Professor of the Public Understanding of Risk
Cambridge University

David Spiegelhalter is the Winton Professor for the Public Understanding of Risk, and Professor of Biostatistics, at the University of Cambridge. His background is in medical statistics, particularly the use of Bayesian methods in clinical trials, health technology assessment and drug safety. In 2014 he was awarded a Knighthood for services to statistics.

David Spiegelhalter is a statistician who has pioneered the modelling of risk in medical contexts. He has brought statistical methodology into the heart of clinical performance monitoring and has worked extensively to improve general understanding of mathematical uncertainty. In his post he leads a small team ( that attempts to improve the way in which the quantitative aspects of risk and uncertainty are discussed in society

An expert on medical statistics, David has played a leading role in a number of public inquiries and was part of the Joint British Societies team that developed revised guidelines for cardiovascular care. He is also a popular and respected communicator of scientific concepts and has written numerous books and newspaper articles explaining the nature of risk, uncertainty and statistics.

He has over 190 refereed publications and is co-author of 6 textbooks, as well as The Norm Chronicles (with Michael Blastland). He is an Honorary Fellow of the Institute for Risk Management, an Honorary Fellow of The Royal College of Physicians, was elected Fellow of the Royal Society in 2005 and awarded an OBE in 2006 for services to medical statistics.

Professor David Spiegelhalter FRS will be speaking at:

Panel Discussion and Q&A – Communicating Research & Evidence, How do you convey the relative risks of smoking and e-cigarettes based on what is currently known about them?

- 10:25 - 10:45

Balanced communication of risks and evidence

- 10:05 - 10:25

« Back to previous page